BlueGnome is a specialist supplier of products from the investigation of genetic abnormalities associated with developmental delay, cancer and infertility. BlueGnome’s 24sure technology is widely used by IVF centers to selectively implant chromosomally normally embryos and so improve IVF rates. BlueGnome is a winner of the Queens Award for Innovation and has won multiple awards as one of the UK’s fastest growing biotechs.